AIMS: This study examines the capabilities of an actively targeting superparamagnetic nanoparticle to specifically deliver therapeutic and MRI contrast agents to cancer cells. MATERIALS & METHODS: Iron oxide nanoparticles were synthesized and conjugated to both a chemotherapeutic agent, methotrexate, and a targeting ligand, chlorotoxin, through a poly(ethylene glycol) linker. Cytotoxicity of this nanoparticle conjugate was evaluated by Alamar Blue cell viability assays, while tumor-cell specificity was examined in vitro and in vivo by MRI. RESULTS & DISCUSSION: Characterization of these multifunctional nanoparticles confirms the successful attachment of both drug and targeting ligands. The targeting nanoparticle demonstrated preferential accumulation and increased cytotoxicity in tumor cells. Furthermore, prolonged retention of these nanoparticles was observed within tumors in vivo. CONCLUSION: The improved specificity, extended particle retention and increased cytotoxicity toward tumor cells demonstrated by this multifunctional nanoparticle system suggest that it possesses potential for applications in cancer diagnosis and treatment.
AIMS: This study examines the capabilities of an actively targeting superparamagnetic nanoparticle to specifically deliver therapeutic and MRI contrast agents to cancer cells. MATERIALS & METHODS:Iron oxide nanoparticles were synthesized and conjugated to both a chemotherapeutic agent, methotrexate, and a targeting ligand, chlorotoxin, through a poly(ethylene glycol) linker. Cytotoxicity of this nanoparticle conjugate was evaluated by Alamar Blue cell viability assays, while tumor-cell specificity was examined in vitro and in vivo by MRI. RESULTS & DISCUSSION: Characterization of these multifunctional nanoparticles confirms the successful attachment of both drug and targeting ligands. The targeting nanoparticle demonstrated preferential accumulation and increased cytotoxicity in tumor cells. Furthermore, prolonged retention of these nanoparticles was observed within tumors in vivo. CONCLUSION: The improved specificity, extended particle retention and increased cytotoxicity toward tumor cells demonstrated by this multifunctional nanoparticle system suggest that it possesses potential for applications in cancer diagnosis and treatment.
Authors: Omid C Farokhzad; Sangyong Jon; Ali Khademhosseini; Thanh-Nga T Tran; David A Lavan; Robert Langer Journal: Cancer Res Date: 2004-11-01 Impact factor: 12.701
Authors: Christoph Alexiou; Roswitha J Schmid; Roland Jurgons; Marcus Kremer; Gerhard Wanner; Christian Bergemann; Ernst Huenges; Thomas Nawroth; Wolfgang Arnold; Fritz G Parak Journal: Eur Biophys J Date: 2006-01-31 Impact factor: 1.733
Authors: G Ramachandra Reddy; Mahaveer S Bhojani; Patrick McConville; Jonathan Moody; Bradford A Moffat; Daniel E Hall; Gwangseong Kim; Yong-Eun L Koo; Michael J Woolliscroft; James V Sugai; Timothy D Johnson; Martin A Philbert; Raoul Kopelman; Alnawaz Rehemtulla; Brian D Ross Journal: Clin Cancer Res Date: 2006-11-15 Impact factor: 12.531
Authors: Mehmet V Yigit; Leyun Zhu; Marytheresa A Ifediba; Yong Zhang; Kevin Carr; Anna Moore; Zdravka Medarova Journal: ACS Nano Date: 2010-12-31 Impact factor: 15.881
Authors: Song Ge; Xiangyang Shi; Kai Sun; Changpeng Li; James R Baker; Mark M Banaszak Holl; Bradford G Orr Journal: J Phys Chem C Nanomater Interfaces Date: 2009-08-06 Impact factor: 4.126
Authors: Chen Fang; Kui Wang; Zachary R Stephen; Qingxin Mu; Forrest M Kievit; Daniel T Chiu; Oliver W Press; Miqin Zhang Journal: ACS Appl Mater Interfaces Date: 2015-03-18 Impact factor: 9.229